Lv33
236 积分 2023-09-26 加入
Advancements in combining targeted therapy and immunotherapy for colorectal cancer
2天前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
2天前
已完结
Problematic crossovers in cancer drug trials
28天前
已完结
Single-agent docetaxel (Taxotere) in randomized phase III trials
1个月前
已关闭
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
1个月前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
1个月前
已完结
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
1个月前
已完结
[Indications and limits of breast conserving treatment]
2个月前
已关闭
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition
2个月前
已完结
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
2个月前
已完结
皖公网安备34019202002308
